open access

Vol 9, No 1 (2024)
Research paper
Published online: 2023-04-21
Get Citation

Risk factors related to COVID-19 survival and mortality: a cross-sectional-descriptive study in regional COVID-19 registry in Fasa, Iran

Shahnaz Karimi1, Maral Eidizadeh2, Maryam Kazemi3, Sanaz Rustaee1, Azizallah Dehghan3, Mostafa Bijani4
·
Disaster Emerg Med J 2024;9(1):8-15.
Affiliations
  1. Department of Medical Surgical Nursing, School of Nursing, Fasa University of Medical Sciences, Fasa, Iran, Islamic Republic Of
  2. Student Research Committee, School of Nursing, Fasa University of Medical Sciences, Fasa, Iran
  3. Noncommunicable Diseases Research Center (NCDRC), Fasa University of Medical Sciences, Fasa, Iran
  4. Department of Medical Surgical Nursing, School of Nursing, Fasa University of Medical Sciences, Fasa, Iran

open access

Vol 9, No 1 (2024)
ORIGINAL ARTICLES
Published online: 2023-04-21

Abstract

INTRODUCTION: The COVID-19 pandemic, as the most important health challenge in the world today, has made numerous irretrievable damages to the social, economic, and health dimensions of societies, especially in developing countries. An essential measure that can be taken to prevent and control the disease is to identify risk factors related to its prognosis and mortality rate. Therefore, this study aimed at investigating COVID-19 survival and mortality risk factors and their relationship with the demographic characteristics of the subjects diagnosed with the disease. MATERIAL AND METHODS: The present study is cross-sectional and descriptive. The samples consist of 1395 patients diagnosed with COVID-19 admitted to medical centers affiliated with Fasa University of Medical Sciences. The subjects were selected by census sampling. Data were collected using demographic information forms, paraclinical and radiological tests, and clinical examinations. Data were analyzed using SPSS version 18 via descriptive tests, paired t-tests, one-way ANOVA, and post hoc tests. RESULTS: According to the data, the participants’ average age was 57.72 ± 4.63 years, and most of them (56.41%) were male. The mortality rate among the participants was estimated to be 13.19%. The results of the study showed a significant relationship between the survival status of patients with COVID-19 and underlying chronic diseases such as diabetes and cardiovascular and renal diseases (p < 0.05). CONCLUSIONS: Identifying high-risk groups is an important measure that health professionals should consider in controlling epidemics. The findings of this study showed that the presence of underlying chronic diseases such as diabetes and cardiac and renal conditions, which are associated with immune system defects, are among the most important factors related to the COVID-19 mortality.

Abstract

INTRODUCTION: The COVID-19 pandemic, as the most important health challenge in the world today, has made numerous irretrievable damages to the social, economic, and health dimensions of societies, especially in developing countries. An essential measure that can be taken to prevent and control the disease is to identify risk factors related to its prognosis and mortality rate. Therefore, this study aimed at investigating COVID-19 survival and mortality risk factors and their relationship with the demographic characteristics of the subjects diagnosed with the disease. MATERIAL AND METHODS: The present study is cross-sectional and descriptive. The samples consist of 1395 patients diagnosed with COVID-19 admitted to medical centers affiliated with Fasa University of Medical Sciences. The subjects were selected by census sampling. Data were collected using demographic information forms, paraclinical and radiological tests, and clinical examinations. Data were analyzed using SPSS version 18 via descriptive tests, paired t-tests, one-way ANOVA, and post hoc tests. RESULTS: According to the data, the participants’ average age was 57.72 ± 4.63 years, and most of them (56.41%) were male. The mortality rate among the participants was estimated to be 13.19%. The results of the study showed a significant relationship between the survival status of patients with COVID-19 and underlying chronic diseases such as diabetes and cardiovascular and renal diseases (p < 0.05). CONCLUSIONS: Identifying high-risk groups is an important measure that health professionals should consider in controlling epidemics. The findings of this study showed that the presence of underlying chronic diseases such as diabetes and cardiac and renal conditions, which are associated with immune system defects, are among the most important factors related to the COVID-19 mortality.

Get Citation

Keywords

COVID-19; risk factors; survival status; underlying diseases

About this article
Title

Risk factors related to COVID-19 survival and mortality: a cross-sectional-descriptive study in regional COVID-19 registry in Fasa, Iran

Journal

Disaster and Emergency Medicine Journal

Issue

Vol 9, No 1 (2024)

Article type

Research paper

Pages

8-15

Published online

2023-04-21

Page views

352

Article views/downloads

221

DOI

10.5603/DEMJ.a2023.0017

Bibliographic record

Disaster Emerg Med J 2024;9(1):8-15.

Keywords

COVID-19
risk factors
survival status
underlying diseases

Authors

Shahnaz Karimi
Maral Eidizadeh
Maryam Kazemi
Sanaz Rustaee
Azizallah Dehghan
Mostafa Bijani

References (22)
  1. Bidzan-Bluma I, Bidzan M, Jurek P, et al. A Polish and German population study of quality of life, well-being, and life satisfaction in older adults during the COVID-19 pandemic. Front Psychiatry. 2020; 11: 585813.
  2. Toquero C. Challenges and opportunities for higher education amid the COVID-19 pandemic: the philippine context. Pedagogical Research. 2020; 5(4): em0063.
  3. Zhuo K, Gao C, Wang X, et al. Stress and sleep: a survey based on wearable sleep trackers among medical and nursing staff in Wuhan during the COVID-19 pandemic. Gen Psychiatr. 2020; 33(3): e100260.
  4. Solomon MD, McNulty EJ, Rana JS, et al. The COVID-19 pandemic and the incidence of acute myocardial infarction. N Engl J Med. 2020; 383(7): 691–693.
  5. Balcom EF, Nath A, Power C. Acute and chronic neurological disorders in COVID-19: potential mechanisms of disease. Brain. 2021; 144(12): 3576–3588.
  6. Daniel SJ. Education and the COVID-19 pandemic. Prospects (Paris). 2020; 49(1-2): 91–96.
  7. Pelicioni PHS, Lord SR. COVID-19 will severely impact older people's lives, and in many more ways than you think! Braz J Phys Ther. 2020; 24(4): 293–294.
  8. Rantanen T, Eronen J, Kauppinen M, et al. Life-space mobility and active aging as factors underlying quality of life among older people before and during COVID-19 lockdown in finland-a longitudinal study. J Gerontol A Biol Sci Med Sci. 2021; 76(3): e60–e67.
  9. Ramakrishnan RK, Kashour T, Hamid Q, et al. Unraveling the mystery surrounding post-acute sequelae of COVID-19. Front Immunol. 2021; 12: 686029.
  10. Butler MJ, Barrientos RM. The impact of nutrition on COVID-19 susceptibility and long-term consequences. Brain Behav Immun. 2020; 87: 53–54.
  11. Dessie ZG, Zewotir T. Mortality-related risk factors of COVID-19: a systematic review and meta-analysis of 42 studies and 423,117 patients. BMC Infect Dis. 2021; 21(1): 855.
  12. Hu K, Lin L, Liang Y, et al. COVID-19: risk factors for severe cases of the Delta variant. Aging (Albany NY). 2021; 13(20): 23459–23470.
  13. Wostyn P. COVID-19 and chronic fatigue syndrome: Is the worst yet to come? Med Hypotheses. 2021; 146: 110469.
  14. Rajpal A, Rahimi L, Ismail-Beigi F. Factors leading to high morbidity and mortality of COVID-19 in patients with type 2 diabetes. J Diabetes. 2020; 12(12): 895–908.
  15. Shastri MD, Shukla SD, Chong WC, et al. Smoking and COVID-19: What we know so far. Respir Med. 2021; 176: 106237.
  16. Ma RCW, Holt RIG. COVID-19 and diabetes. Diabet Med. 2020; 37(5): 723–725.
  17. Wang K, Wu C, Xu J, et al. Factors affecting the mortality of patients with COVID-19 undergoing surgery and the safety of medical staff: A systematic review and meta-analysis. EClinicalMedicine. 2020; 29: 100612.
  18. Gao YD, Ding M, Dong X, et al. Risk factors for severe and critically ill COVID-19 patients: A review. Allergy. 2021; 76(2): 428–455.
  19. Jothimani D, Venugopal R, Abedin MF, et al. COVID-19 and the liver. J Hepatol. 2020; 73(5): 1231–1240.
  20. Chadeau-Hyam M, Bodinier B, Elliott J, et al. Risk factors for positive and negative COVID-19 tests: a cautious and in-depth analysis of UK biobank data. Int J Epidemiol. 2020; 49(5): 1454–1467.
  21. Mirjalili M, Dehghani M, Raadabadi M, et al. Death risk among COVID-19 patients in Yazd, Iran: a hospital-based case-cohort study. Journal of Military Medicine. 2021; 23(3): 274–282.
  22. Alamdari NM, Afaghi S, Rahimi FS, et al. Mortality risk factors among hospitalized COVID-19 patients in a major referral center in iran. Tohoku J Exp Med. 2020; 252(1): 73–84.

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By VM Media Group sp. z o.o., ul. Świętokrzyska 73, 80–180 Gdańsk, Poland
tel.:+48 58 320 94 94, fax:+48 58 320 94 60, e-mail: viamedica@viamedica.pl